High-sensitivity methods for cardiac troponins: The mission is not over yet

Aldo Clerico1, Martina Zaninotto2, Claudio Passino1

  • 1Fondazione CNR-Regione Toscana, G. Monasterio, Pisa, Italy; Scuola Superiore Sant'Anna, Pisa, Italy.

Insights

High-sensitivity cardiac troponin (hs-cTn) assays are crucial for diagnosing Acute Coronary Syndromes. New methods are needed to distinguish reversible from irreversible myocardial injury based on specific circulating troponin forms.

Area of Science:

  • Cardiology
  • Biomarker Analysis
  • Clinical Chemistry

Background:

  • Cardiac troponin (cTn) measurement is the gold standard for diagnosing Acute Coronary Syndromes (ACS).
  • High-sensitivity cardiac troponin (hs-cTn) assays are widely used but present challenges in differentiating myocardial injury mechanisms.
  • Distinguishing between reversible and irreversible cardiomyocyte injury based on biomarker release remains a key clinical concern.

Purpose of the Study:

  • To review critical analytical and clinical issues of current hs-cTn methods.
  • To discuss the potential of novel hs-cTn assays for differentiating myocardial injury.
  • To highlight the need for next-generation hs-cTn assays.

Main Methods:

  • Review of experimental and clinical studies on hs-cTn assays.
  • Analysis of circulating troponin isoforms (cTnI and cTnT) in myocardial injury.
  • Discussion of immunometric immunoassays and chromatographic techniques for novel hs-cTn detection.

Main Results:

  • Current hs-cTn methods struggle to differentiate pathophysiological mechanisms of biomarker release.
  • Distinct circulating forms of cTnI and cTnT are associated with reversible versus irreversible myocardial injury.
  • New assay generations could offer specificity for these different troponin forms.

Conclusions:

  • Next-generation hs-cTn methods, potentially using immunometric immunoassays or chromatography, are needed.
  • These assays should be specific for circulating troponin peptide forms indicative of reversible or irreversible myocardial injury.
  • Such advancements will further refine the diagnosis, prognosis, and management of cardiac diseases.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
460
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
55
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
191
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
281
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
105